Cadence Bank’s Genmab GMAB Stock Holding History

Cadence Bank’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,216	Closed	-$206K	–	200
2021 Q4	$206K	Hold	5,216	–	–	0.03%	195
2021 Q3	$228K	Hold	5,216	–	–	0.03%	181
2021 Q2	$213K	Buy	+5,216	New	+$201K	0.03%	188
2021 Q1	–	Sell	-5,216	Closed	-$212K	–	205
2020 Q4	$212K	Buy	+5,216	New	+$195K	0.03%	204

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cadence Bank's GMAB Position: Q1 2022 in Review

Cadence Bank sold out of Genmab (GMAB) in Q1 2022, closing a stake of 5,216 shares — an estimated $206K sold.

Cadence Bank first reported a position in GMAB in Q4 2020 and held it in 4 quarters. The position peaked at $228K in Q3 2021. 204 funds tracked by Wall St. Rank hold GMAB as of Q1 2022.

Cadence Bank reported no remaining Genmab position as of Q1 2022 after selling out during the quarter.
Cadence Bank sold 5,216 Genmab shares in Q1 2022, an estimated $206K.
Cadence Bank first reported a position in Genmab in Q4 2020 and held it in 4 quarters.
Cadence Bank's Genmab position peaked at $228K in Q3 2021.
204 funds tracked by Wall St. Rank held Genmab as of Q1 2022.

Based on Cadence Bank's 13F filing for Q1 2022, filed 13 May 2022.